Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-05-09 | 2024-05-30 | 227489 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94877 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-15 | 170784 |
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151456 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2022-07-25 | 2023-01-12 | 165456 |
TEVA-FEBUXOSTAT | 80MG | TABLET | Resolved | 2023-10-05 | 2024-02-08 | 206434 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2017-09-21 | 2017-11-07 | 22948 |
TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2019-07-02 | 2019-08-06 | 88158 |
TEVA-FENTANYL | 75MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173013 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173016 |
TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173019 |
TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173022 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2023-08-17 | 2023-10-04 | 202265 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2020-04-23 | 2020-05-21 | 113025 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-06-30 | 2022-09-23 | 163939 |
TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2024-01-25 | 2024-05-09 | 217223 |
TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |